Debiopharm, ThinkingNodeLife.ai join forces to advance AI-driven cancer drug development
Debiopharm, an independent biopharmaceutical company based in Switzerland, has forged a collaborative partnership with USA’s ThinkingNodeLife.ai (TNL), a pioneer in AI Digital Cells Lab, to advance the development of a cutting-edge cancer drug. This strategic alliance combines TNL’s AI Digital Cells Lab platform with Debiopharm’s extensive pharmaceutical expertise, marking a significant leap in oncology drug […]